ECDC risk assessment: 2009 influenza A(H1N1) pandemic (Update 20 May 2009)
A new influenza A(H1N1) virus was first identified by US CDC on 17 April 2009 in samples from two Californian children. It was reported in MMWR on 21 April . The basic genetic structure of the virus which was first described in Eurosurveillance on 30 April , demonstrated that the virus had many genetic elements from porcine (swine) influenza. The new virus was thus initially called ‘swine flu’ even though its pig origin later came into question, and it is now clearly evident that it can spread from human to human.
Rapid risk assessment: Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – seventh update
25 Mar 2020 - On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China. On 9 January 2020, China CDC reported a novel coronavirus as the causative agent of this outbreak, coronavirus disease 2019 (COVID-19).
Rapid risk assessment: Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – sixth update
12 Mar 2020 - Since ECDC’s fifth update on novel coronavirus published on 2 March 2020 and as of 11 March, the number of cases and deaths reported in the EU/EEA and the UK has been rising, mirroring the trends seen in China in January-early February and in northern Italy in late February. If this trend continues, based on the quick pace of growth of the epidemic observed in China and northern Italy, it is likely that in days, or a small number of weeks, similar situations may be seen in other EU/EEA Member States and the UK.
Rapid risk assessment: Outbreak of novel coronavirus disease 2019 (COVID-19): increased transmission globally – fifth update
2 Mar 2020 - As of 2 March, 66 countries have reported cases of of novel coronavirus disease 2019. The risk associated with COVID-19 infection for people in the EU/EEA and UK is currently considered to be moderate to high, based on the probability of transmission and the impact of the disease.